ARTICLE | Clinical News
Triapine: Phase I
March 6, 2000 8:00 AM UTC
In a single dose U.S. Phase I study, Triapine was well tolerated at each of nine dose levels when given intravenously as a 2-hour infusion every 4 weeks. At the highest dose level, no significant toxi...